Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OMADACYCLINE vs OMALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OMADACYCLINE vs OMALIZUMAB: Safety Overview

Metric OMADACYCLINE OMALIZUMAB
Total FAERS Reports 1,079 63,846
Deaths Reported 79 1,713
Death Rate 7.3% 2.7%
Hospitalizations 231 11,178
Average Patient Age 60.8 yrs 51.0 yrs
% Female Patients 55.1% 72.5%
FDA Approval Date Oct 2, 2018 N/A
Manufacturer Paratek Pharmaceuticals, Inc. CELLTRION, Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription